Predictores de uso de anticoagulantes orales directos en tromboembolia pulmonar aguda

INTRODUCTION: In the last decade, direct oral anticoagulants (DOACs) have been incorporated as an anticoagulation tool in patients with acute pulmonary thromboembolism (PTE). Although they have a better pharmacological profile than vitamin K antagonists (VKA), the use of these drugs is not massive....

Descripción completa

Detalles Bibliográficos
Autores principales: Barrionuevo, Belén, Scatularo, Cristhian E., Antoniolli, Melisa, Lerech, Ezequiel, Morcos, Ludmila, Bernal, Maico I., Cigalini, Ignacio M., Zaidel, Ezequiel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Permanyer Publications 2022
Materias:
Artículo De Investigación
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681506/
https://www.ncbi.nlm.nih.gov/pubmed/36413692
http://dx.doi.org/10.24875/ACM.22000038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681506/
https://www.ncbi.nlm.nih.gov/pubmed/36413692
http://dx.doi.org/10.24875/ACM.22000038

Ejemplares similares